Single-Dose Phase 1 Study of TAK-792

Conditions

• Healthy Male Adults Participants

Interventions

• DRUG: TAK-792 30 mg
• DRUG: TAK-792 30 mg placebo
• DRUG: TAK-792 100 mg
• DRUG: TAK-792 100 mg placebo
• DRUG: TAK-792 250 mg
• DRUG: TAK-792 250 mg placebo
• DRUG: TAK-792 500 mg
• DRUG: TAK-792 500 mg placebo
• DRUG: TAK-792 750 mg
• DRUG: TAK-792 750 mg placebo
• DRUG: TAK-792 1250 mg
• DRUG: TAK-792 1250 mg placebo

Sponsor

Takeda